Quality and Compliance for ATMPs – A Strategic Enabler for Patient Access
Afifa TradSenior consultant, Pharma QA – GBA Key2Compliance Advanced Therapy Medicinal Products (ATMPs) are transforming the treatment landscape for complex and previously untreatable diseases. By leveraging gene therapy, cell-based treatments, and tissue engineering, these therapies offer truly personalized solutions. But with innovation comes complexity—and success depends on one key factor: a robust strategy for quality […]
Proud Silver Sponsor at ATMP Sweden 2024 – Meet Us in Malmö!
We’re thrilled to announce that GBA Key2Compliance will be attending ATMP Sweden 2024 as a proud Silver Sponsor! Join us on November 25-26 in Malmö at Sweden’s premiere annual conference for ATMP stakeholders, ATMP Sweden, bringing together experts from pre-clinical research to reimbursement and standard of care. Our experts, Sara Falkenklint and Maria Axelsson, will […]
Unique project brings GMP education to the ATMP-area through VR- and on-demand training
Advanced therapy medicinal products (ATMPs) based on genes, tissues or cells offer revolutionary new opportunities for treatments of disease and injury. One of the challenges with ATMPs is that Good Manufacturing Practice (GMP) is necessary to ensure control and safety as research transitions to production. However, since the new manufacturing processes for ATMPs often are […]